<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(4)</volume><submitter>Wang Y</submitter><journal>Blood advances</journal><pagination>1372-1380</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12927045</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma</pubmed_title><pmcid>PMC12927045</pmcid><pubmed_authors>Reagan P</pubmed_authors><pubmed_authors>Kugathasan L</pubmed_authors><pubmed_authors>Velayati A</pubmed_authors><pubmed_authors>Barta S</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Hill B</pubmed_authors><pubmed_authors>Stack A</pubmed_authors><pubmed_authors>Pophali P</pubmed_authors><pubmed_authors>Stanisic A</pubmed_authors><pubmed_authors>Tun A</pubmed_authors><pubmed_authors>Martin P</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Kahl B</pubmed_authors><pubmed_authors>Ayyappan S</pubmed_authors><pubmed_authors>Brooks T</pubmed_authors><pubmed_authors>Merryman R</pubmed_authors><pubmed_authors>Greenwell I</pubmed_authors><pubmed_authors>Jain P</pubmed_authors><pubmed_authors>Danilov A</pubmed_authors><pubmed_authors>Lossos I</pubmed_authors><pubmed_authors>Bond D</pubmed_authors><pubmed_authors>Baidoun F</pubmed_authors><pubmed_authors>Mou E</pubmed_authors><pubmed_authors>Messmer M</pubmed_authors><pubmed_authors>Young P</pubmed_authors><pubmed_authors>Pongas G</pubmed_authors><pubmed_authors>Narkhede M</pubmed_authors><pubmed_authors>Ryan C</pubmed_authors><pubmed_authors>Nizamuddin I</pubmed_authors><pubmed_authors>Moyo T</pubmed_authors><pubmed_authors>Ouchveridze E</pubmed_authors><pubmed_authors>Portell C</pubmed_authors><pubmed_authors>Larson M</pubmed_authors><pubmed_authors>Anna J</pubmed_authors><pubmed_authors>Kamdar M</pubmed_authors><pubmed_authors>Argao C</pubmed_authors><pubmed_authors>Karmali R</pubmed_authors><pubmed_authors>Munoz J</pubmed_authors><pubmed_authors>Bhansali R</pubmed_authors><pubmed_authors>Gerber D</pubmed_authors><pubmed_authors>Grover N</pubmed_authors><pubmed_authors>Maddocks K</pubmed_authors><pubmed_authors>Hwang S</pubmed_authors><pubmed_authors>Harris Z</pubmed_authors><pubmed_authors>Ruan J</pubmed_authors><pubmed_authors>Banaszak L</pubmed_authors><pubmed_authors>Ghosh N</pubmed_authors><pubmed_authors>Mehta A</pubmed_authors><pubmed_authors>Khan N</pubmed_authors><pubmed_authors>Villa D</pubmed_authors><pubmed_authors>Joseph A</pubmed_authors><pubmed_authors>Cohen J</pubmed_authors><pubmed_authors>Cerhan J</pubmed_authors><pubmed_authors>Kumar A</pubmed_authors><pubmed_authors>Alhaj Moustafa M</pubmed_authors><pubmed_authors>Maurer M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-16T18:25:02.968Z</modification><creation>2026-07-09T11:15:10.282Z</creation></dates><accession>S-EPMC12927045</accession><cross_references/></HashMap>